Business

OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET

ROCHESTER, Mich., July 23, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies

articleOptimizerx CorporationJuly 23, 20205/company/optimizerx-corp/news/optimizerx-sets-second-quarter-2020-conference-call-for-wednesday-august-5-2020-at-430-pm-et
OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET

About this update from Optimizerx Corporation

[{"type":"text","content":"ROCHESTER, Mich., July 23, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Wednesday, August 5, 2020 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. The financial results will be issued in a press release prior to the call.\n OptimizeRx management will host the call, followed by a question and answer period. Date: Wednesday, August 5, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-866-248-8441International dial-in number: 1-323-289-6576Conference ID: 1161129 Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact CMA at 1-949-432-7566. A replay of the call will be available after 7:30 p.m. Eastern time on the same day through August 26, 2020, as well as available for replay via the Investors section of the OptimizeRx website at optimizerx.com/investors. Toll-free replay number: 1-844-512-2921International replay number: 1-412-317-6671Replay ID: 1161129 About OptimizeRxOptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at the point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRx’s network reaches more than 60% of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a provider’s workflow through leading electronic health platforms. OptimizeRx’s fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes. For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com. Important Cautions Regarding Forward Looking StatementsThis press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-look...

More updates from Optimizerx Corporation